BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6142065)

  • 1. The function and distribution of different fimbriae on strains of Actinomyces viscosus and Actinomyces naeslundii.
    Cisar JO; Sandberg AL; Mergenhagen SE
    J Dent Res; 1984 Mar; 63(3):393-6. PubMed ID: 6142065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actinomyces adsorption mediated by type-1 fimbriae.
    Clark WB; Wheeler TT; Lane MD; Cisar JO
    J Dent Res; 1986 Sep; 65(9):1166-8. PubMed ID: 2874164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of bacterial adhesion in the oral cavity.
    Mergenhagen SE; Sandberg AL; Chassy BM; Brennan MJ; Yeung MK; Donkersloot JA; Cisar JO
    Rev Infect Dis; 1987; 9 Suppl 5():S467-74. PubMed ID: 2891180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro attachment, salivary agglutination, and surface fibril density of fresh Actinomyces isolates from two distinct oral surfaces.
    Ellen RP; Sivendra R
    J Dent Res; 1985 May; 64(5):799-803. PubMed ID: 2860145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
    Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
    Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and immunological comparison of surface fibrils of strains representing six taxonomic groups of Actinomyces viscosus and Actinomyces naeslundii.
    Masuda N; Ellen RP; Fillery ED; Grove DA
    Infect Immun; 1983 Mar; 39(3):1325-33. PubMed ID: 6188696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the adsorptive behavior of human strains of Actinomyces viscosus and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Qureshi JV; Gibbons RJ
    Infect Immun; 1981 Jan; 31(1):261-6. PubMed ID: 7216448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.
    Cisar JO; David VA; Curl SH; Vatter AE
    Infect Immun; 1984 Nov; 46(2):453-8. PubMed ID: 6150007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinomyces viscosus fibril antigens detected by immunogold electron microscopy.
    Ellen RP; Buivids IA; Simardone JR
    Infect Immun; 1989 Apr; 57(4):1327-31. PubMed ID: 2564376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of monoclonal antibodies in the study of lactose-sensitive adherence of Actinomyces viscosus T14V.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Reticuloendothel Soc; 1980 Dec; 28(Suppl):73s-79s. PubMed ID: 6108369
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of in vitro attachment of Streptococcus sanguis and Actinomyces viscosus to saliva-treated titanium.
    Wolinsky LE; de Camargo PM; Erard JC; Newman MG
    Int J Oral Maxillofac Implants; 1989; 4(1):27-31. PubMed ID: 2599579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Peros WJ; Gibbons RJ
    Infect Immun; 1981 Apr; 32(1):111-7. PubMed ID: 7216480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coaggregation of human oral Cytophaga species and Actinomyces israelii.
    Kolenbrander PE; Celesk RA
    Infect Immun; 1983 Jun; 40(3):1178-85. PubMed ID: 6133836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.
    Cisar JO; McIntire FC; Vatter AE
    Adv Exp Med Biol; 1978; 107():695-701. PubMed ID: 84522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of fimbriae with the hydrophobicity of Streptococcus sanguis FC-1 and adherence to salivary pellicles.
    Gibbons RJ; Etherden I; Skobe Z
    Infect Immun; 1983 Jul; 41(1):414-7. PubMed ID: 6134679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus.
    Kuramitsu HK; Paul A
    Infect Immun; 1980 Jul; 29(1):83-90. PubMed ID: 6772577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells.
    Brennan MJ; Cisar JO; Vatter AE; Sandberg AL
    Infect Immun; 1984 Nov; 46(2):459-64. PubMed ID: 6150008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.